首页> 美国卫生研究院文献>American Journal of Translational Research >The diagnostic value of microRNA-4787-5p and microRNA-4306 in patients with acute aortic dissection
【2h】

The diagnostic value of microRNA-4787-5p and microRNA-4306 in patients with acute aortic dissection

机译:microRNA-4787-5p和microRNA-4306在急性主动脉夹层中的诊断价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute aortic dissection (AAD) is a life-threatening cardiovascular disease with the high morbidity and mortality. Imaging modalities are the gold standard for the diagnosis of AAD; however, they are not always available in emergency department. Biomarker-assisted diagnosis is important for the early treatment of AAD. The aim of the present study was to identify potential microRNA (miRNA) biomarkers for AAD. Differentially expressed plasma miRNAs between AAD patients and age-matched healthy volunteers were analyzed by miRNA microarray. Quantitative RT-PCR was further performed to verify the expression of selected miRNAs (miR-4787-5p and miR-4306) with an increased number of samples. Receiver operating characteristic (ROC) analysis was used to assess the diagnostic value of miR-4787-5p and miR-4306 as biomarkers for distinguishing AAD. Using TargetScan and miRanda, miR-4787-5p and miR-4306 were selected to predict target gene related to cytokines detecting by dual luciferase assay and western blotting. Nine upregulated and twelve downregulated miRNAs were identified in the circulating plasma of AAD patients. qRT-PCR verified statistically consistent expression of two selected miRNAs with microarray analysis. ROC analyses demonstrated that miR-4787-5p and miR-4306 were specific and sensitive for the early diagnosis of AAD. Bioinformatic predictions and dual luciferase assay suggested that polycystin-1 (PKD1) and transforming growth factor-β1 (TGF-β1) were respectively direct target of miR-4787-5p and miR-4306. Furthermore, the protein expression of the downstream targets of PKD1 and TGF-β1 were significantly reduced following overexpression of miR-4787-5p and miR-4306. These results revealed that miR-4787-5p and miR-4306 could be developed as diagnostic potential biomarkers for AAD, and they could be involved in the pathogenesis of AAD.
机译:急性主动脉夹层(AAD)是一种威胁生命的心血管疾病,具有较高的发病率和死亡率。成像方式是诊断AAD的金标准;但是,它们并不总是在急诊科中可用。生物标志物辅助诊断对于AAD的早期治疗很重要。本研究的目的是确定AAD的潜在microRNA(miRNA)生物标记。通过miRNA芯片分析AAD患者和年龄匹配的健康志愿者之间差异表达的血浆miRNA。进一步进行定量RT-PCR,以验证样品数量增加时所选miRNA(miR-4787-5p和miR-4306)的表达。接收者操作特征(ROC)分析用于评估miR-4787-5p和miR-4306作为区分AAD的生物标志物的诊断价值。使用TargetScan和miRanda,选择miR-4787-5p和miR-4306来预测与通过双重荧光素酶测定和Western印迹检测细胞因子相关的靶基因。在AAD患者的循环血浆中鉴定出9个上调的miRNA和12个下调的miRNA。 qRT-PCR通过微阵列分析验证了两个选定miRNA的统计学一致性表达。 ROC分析表明miR-4787-5p和miR-4306对AAD的早期诊断具有特异性和敏感性。生物信息学预测和双重荧光素酶测定表明,多囊藻蛋白-1(PKD1)和转化生长因子-β1(TGF-β1)分别是miR-4787-5p和miR-4306的直接靶标。此外,在miR-4787-5p和miR-4306过表达后,PKD1和TGF-β1下游靶标的蛋白表达显着降低。这些结果表明,miR-4787-5p和miR-4306可以作为AAD的诊断潜在生物标志物开发,并且它们可能参与AAD的发病机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号